GenDx

28/05/2026

Read our new blog post👇

Understand the significance of HLA in tumors and its potential in advancing HLA-restricted precision medicine therapies.

18/05/2026

Single Locus HLA typing to maximize flexibility on ONT.

NGSgo®-ProntoFLX was designed with this goal in min, allowing labs to have the extra flexibility of singleplex or duplex formats.

"NGSgo®-ProntoFLX can be seamlessly integrated into labs that have already validated NGSgo®-ProntoAmp and NGS-ProntoPrep. But it can also easily be integrated if just used by itself.”
– Mattijs Punt, Jr Project Manager R&D.

Watch the video to learn more👇
https://youtu.be/OWTng3MvCDA

17/05/2026

High-quality HLA typing starts with reliable amplification🔬

To support laboratories in achieving fast and reliable results, we published a comprehensive application note demonstrating the powerful capabilities of the 𝐍𝐆𝐒𝐠𝐨-𝐏𝐫𝐨𝐧𝐭𝐨𝐀𝐦𝐩 𝐦𝐮𝐥𝐭𝐢𝐩𝐥𝐞𝐱 𝐚𝐦𝐩𝐥𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐚𝐬𝐬𝐚𝐲.

Whether your lab uses blood or buccal swab samples, NGSgo-ProntoAmp delivers a streamlined, high-throughput solution with excellent sequencing quality.

Download the full application note on our website
🔗 https://www.gendx.com/2026/04/application-note-robust-hla-typing-with-ngsgo-prontoamp/

13/05/2026

The 39th annual European Federation for Immunogenetics Conference 2026 brought together researchers, clinicians, and industry experts from around the world in Edinburgh to discuss the latest advances in immunogenetics and histocompatibility.

Our colleague Cynthia Kramer, PhD, Scientist at GenDx, attended the conference and shares her key scientific highlights below.

To the blog post 👇
🔗 https://www.gendx.com/2026/05/efi-conference-insights/

11/05/2026

08/05/2026

"𝐸𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛 𝑑𝑜𝑒𝑠 𝑛𝑜𝑡 𝑒𝑛𝑑 𝑤ℎ𝑒𝑛 𝑡ℎ𝑒 𝑐𝑜𝑢𝑟𝑠𝑒 𝑓𝑖𝑛𝑖𝑠ℎ𝑒𝑠, 𝑤𝑒 𝑠𝑒𝑒 𝑖𝑡 𝑎𝑠 𝑎 𝑙𝑜𝑛𝑔-𝑡𝑒𝑟𝑚 𝑝𝑎𝑟𝑡𝑛𝑒𝑟𝑠ℎ𝑖𝑝, 𝑠𝑢𝑝𝑝𝑜𝑟𝑡𝑒𝑑 𝑏𝑦 𝑜𝑢𝑟 𝑡𝑒𝑐ℎ𝑛𝑖𝑐𝑎𝑙 𝑡𝑒𝑎𝑚, 𝑚𝑜𝑛𝑡ℎ𝑙𝑦 𝑤𝑒𝑏𝑖𝑛𝑎𝑟𝑠, 𝑎𝑛𝑑 𝑡ℎ𝑒 𝑢𝑝𝑐𝑜𝑚𝑖𝑛𝑔 𝐺𝑒𝑛𝐷𝑥 𝐴𝑐𝑎𝑑𝑒𝑚𝑦."
Veerle Van Meervelt, PhD, Global Education Manager

Join our upcoming hands-on training course on HLA typing with Illumina sequencing.

Whether you are looking to refine your lab techniques or deepen your understanding of complex data interpretation, this intensive three-day programme at GenDx Headquarters in Utrecht is designed to elevate your expertise.

📅 September 30 - October 2, 2026
📍 Utrecht, Netherlands

👉 Register here:
https://www.gendx.com/registration-training-course-september-2026/

06/05/2026

Register for NGSengine® Case Study Webinar (Intermediate Level).

📅 May 20
🕛 12:00 CEST︱19:00 CEST
📍 Online
🔗https://www.gendx.com/gendx_education/ngsengine-case-study-webinar-intermediate-level/

This month, we will discuss examples of putative new alleles. We aim for an interactive session while performing an in-depth analysis of the sample(s).

Once you are registered, you will receive data files in advance of the webinar. We ask you to analyze the data and think about what you would report. You are invited to share your feedback and interpretation before the webinar, via [email protected].

To receive the data files, please sign up before May 7.

06/05/2026

Curious about our latest developments? We have shared the posters presented at EFI Conference 2026 on our website.

Follow the link below to download them 👇
🔗https://www.gendx.com/education/posters/

04/05/2026

GenDx continues to expand its IVD portfolio in Australia!

NGSengine is now IVD registered, complementing our existing solutions: NGSgo-AmpX V3, NGSgo-MX6-1, NGSgo-ProntoAmp, and NGSgo Library Full Kit.

Together, these solutions support laboratories with a fully IVD integrated NGS workflow 🧪

28/04/2026

Developing a companion diagnostic is complex. Regulatory landscapes, clinical study validation, therapy monitoring... the list is long.

That's where GenDx comes in.

Our CDx Project Manager, Jules Petit walks you through how we support our partners from idea to IVD, and how we contribute to your successful pharmaceutical therapy development.

Watch the full video 👇



https://www.gendx.com/companion-diagnostics/introduction/